Financial Performance - Full year adjusted EBITDA grew 6% year-over-year, reaching $198.9 million, despite significant increases in raw material costs[4] - Fourth quarter net sales increased by 5% year-over-year to $553.9 million, driven by higher selling prices and favorable product mix[7] - Reported net income for the fourth quarter was $5.0 million, up 49% compared to the prior year, while adjusted net income was a loss of $0.5 million, down 119%[5] - Net sales for Q4 2025 were $553.9 million, an increase of 5.3% from $525.6 million in Q4 2024[25] - Gross profit for Q4 2025 was $51.5 million, down 9.3% from $56.7 million in Q4 2024[25] - Operating income for Q4 2025 increased to $10.5 million, compared to $7.7 million in Q4 2024, reflecting a 36.5% growth[25] - Net income for Q4 2025 was $5.0 million, up 49.3% from $3.4 million in Q4 2024[25] - Basic earnings per share (EPS) for Q4 2025 was $0.22, compared to $0.15 in Q4 2024, representing a 46.7% increase[26] - Total operating expenses for Q4 2025 were $50.7 million, slightly up from $49.0 million in Q4 2024[25] - Adjusted EBITDA for the quarter was $33.8 million, compared to $35.0 million in the same quarter last year[46] - Consolidated operating income for the twelve months ended December 31, 2025, was $78.5 million[50] - Adjusted EBITDA for the same period was $198.9 million, with contributions of $153.0 million from Surfactants, $76.4 million from Polymers, and $31.5 million from Specialty Products[50] - The company achieved an EBITDA of $208.0 million for the twelve months ended December 31, 2025[50] Sales and Volume - Global sales volume decreased by 3% year-over-year in the fourth quarter, but was flat when excluding the impact of the Philippines asset divestiture[5] - Polymer volume increased by 11%, contributing to a 1% increase in net sales for the Polymer segment[6] - Surfactant net sales for the fourth quarter were $401.8 million, a 6% increase, despite a 7% decline in sales volume due to lower demand in certain markets[11] Cash Flow and Debt - Free cash flow for the fourth quarter was $25.4 million, supported by a reduction in working capital[5] - The company reduced its net debt by $31.7 million, resulting in a leverage ratio of 2.5[4] - The net debt level decreased by $43.0 million to $494.0 million, with a net debt ratio of 28%[44] - Cash increased by $14.2 million to $132.7 million compared to the previous quarter[44] Expenses and Impairments - The company reported a goodwill impairment charge of $6.2 million in Q4 2025 related to its Mexican reporting unit[30] - The company reported a goodwill impairment of $6,245 thousand for the quarter[40] - Research, development, and technical services expenses increased to $15.7 million in Q4 2025 from $13.8 million in Q4 2024, a rise of 13.9%[25] - Total corporate expenses decreased by 54% to $8,065 thousand for the quarter, primarily due to the non-recurrence of CEO transition expenses[40] - Environmental remediation costs amounted to $1.2 million, while deferred compensation was a negative $0.6 million[50] - Unallocated corporate expenses were $57.8 million, impacting overall profitability[50] Strategic Initiatives - Project Catalyst aims to deliver approximately $100 million in pre-tax savings over the next two years, including site closures and asset decommissioning[14] - The company anticipates continued focus on product development and market expansion in the upcoming quarters[21] Other Financial Metrics - The effective tax rate increased to 21.7% in 2025 from 16.7% in 2024, primarily due to the non-recurrence of favorable deferred tax adjustments[13] - A gain on the sale of assets contributed $11.9 million to net income in Q4 2025[30] - The total pre-tax income for the quarter was $(101) thousand, a decrease from $1,016 thousand in the prior year[35] - The company's total assets increased to $2,357,702 thousand as of December 31, 2025, compared to $2,304,648 thousand in the prior year[42] - Depreciation and amortization expenses totaled $126.0 million, with $85.6 million attributed to Surfactants[50] - The gain on the sale of assets was reported at a negative $15.9 million[50] - Operating income for Surfactants was $67.4 million, while Polymers and Specialty Products reported $43.3 million and $25.6 million, respectively[50] - Other net income contributed $3.5 million to the overall financial results[50]

Exhibit 99.2 Disclaimers Forward-looking Statement We make statements in this Supplemental Information Package that are considered "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which are usually identified by the use of words such as "anticipates," "believes," "estimates," "expects," "intends," "may," "plans," "projects," "seeks," "should ...

Exhibit 99.1 Freshpet, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results Full Year 2025 Net Sales Growth of 13% and Achieves Positive Free Cash Flow Provides Full Year 2026 Outlook Bedminster, N.J. – February 23, 2026 – Freshpet, Inc. ("Freshpet" or the "Company") (Nasdaq: FRPT) today reported financial results for its fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Compared to Prior Year Period Full Year 2025 Financial Highlights Compared to Pri ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 28, 2025 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-32242 Domino's Pizza, Inc. (Exact name of registrant as specified in its charter) DELAWARE (State or other jurisdiction of incorporation or organization) 30 Frank ...

Exhibit 99.1 For Immediate Release Contact: Greg Lemenchick Vice President - Investor Relations investorrelations@dominos.com Domino's Pizza® Announces Fourth Quarter and Fiscal 2025 Financial Results Global retail sales growth (excluding foreign currency impact) of 4.9% for the fourth quarter; 5.4% growth for fiscal 2025 U.S. same store sales growth of 3.7% for the fourth quarter; 3.0% growth for fiscal 2025 International same store sales growth (excluding foreign currency impact) of 0.7% for the fourth qu ...

Exhibit 99.1 MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results ZUG, Switzerland, February 22, 2026 – MoonLake Immunotherapeutics (NASDAQ:MLTX) ("MoonLake" or the "Company"), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announces topline results from the S-OLARIS Phase 2 trial of SLK in patients with radiographic and non-radiographic axSpA ...

Merger and Acquisition - Omnicom completed its merger with IPG on November 26, 2025, with legacy Omnicom shareholders owning approximately 60.6% and legacy IPG shareholders owning approximately 39.4% of the combined company[17]. - The merger was structured as a tax-free reorganization, and IPG's results will only be included in Omnicom's financial statements from the Closing Date onward[18]. - Omnicom exchanged approximately 94% of IPG's outstanding senior notes, totaling $2.76 billion, for new notes issued by Omnicom[19]. - The merger with IPG may result in significant costs exceeding initial expectations, impacting financial condition and cash flows[70]. - There is uncertainty regarding the retention of key management personnel post-merger, which could disrupt operations and client relationships[69]. - The integration of the two companies' operations may face challenges, including managing a larger, more complex business and achieving anticipated cost savings[71]. - The company may not fully realize the expected benefits of the merger, which could affect adjusted earnings per share and cash returns to shareholders[74]. Financial Performance - Revenue for the year ended December 31, 2025, was $17,271.9 million, an increase of $1,582.8 million (10.1%) compared to 2024[158]. - Operating income for 2025 was $444.7 million, a decrease of $1,829.9 million, or 80.4%, from 2024[129]. - Net income for Omnicom Group Inc. was a loss of $54.5 million in 2025, down from a profit of $1,480.6 million in 2024[129]. - Operating margin for 2025 was 2.6%, a significant drop from 14.5% in 2024, representing a decline of 11.9 percentage points[158]. - EBITA for 2025 was $560.5 million, down from $2,362.1 million in 2024, a decrease of $1,801.6 million[158]. - The year-over-year increase in worldwide revenue reflected constant currency growth of $1,458.2 million, or 9.3%[171]. - In 2025, operating expenses included $1,247.0 million related to severance and efficiency initiatives, reducing operating income by $2,141.4 million[159]. Client and Revenue Composition - Omnicom's client base is diverse, with no single industry representing more than 15% of revenue in 2025, and the largest client contributing 2.4% of revenue[34]. - In 2025, the largest client represented approximately 2.4% of total revenue, while the top 100 clients accounted for about 54% of revenue[55]. - The Pharmaceuticals and Healthcare sector accounted for 15% of total revenue in 2025, consistent with previous years[183]. - The Technology sector maintained an 8% share of total revenue across 2023 to 2025[183]. Operational Insights - The company employs approximately 120,000 people globally, with the largest employee base in the United States at around 37,700[38]. - Omnicom's revenue is typically lower in the first and third quarters and higher in the second and fourth quarters, reflecting client spending patterns[28]. - The company focuses on revenue growth and variability of operating expenses as key performance indicators[29]. - Omnicom's business model emphasizes a client-centric approach, facilitating collaboration across multiple agencies to meet specific client needs[25]. Technology and Innovation - Omnicom's new Omni platform integrates AI and data capabilities to enhance marketing services and client performance[26]. - The company is committed to responsible AI practices while evaluating risks related to privacy and data security[27]. - The company has entered into strategic partnerships with leading AI technology firms in 2023 to enhance product and service capabilities using AI[62]. Economic and Market Risks - A period of sustained inflation could lead to increased operating costs, particularly in salary and service costs, affecting overall financial condition[45]. - The company relies on information technology systems and faces cybersecurity risks that could adversely affect business operations and financial results[56]. - Currency exchange rate fluctuations have historically impacted the company's financial condition and will continue to do so in the future[67]. - The company operates in high-growth markets and developing countries, which may lead to longer billing collection cycles and increased operational risks[68]. Compliance and Regulatory Risks - Legal and regulatory risks may limit service scope and affect client relationships, potentially leading to reduced spending on services[79]. - Compliance with evolving privacy and data protection laws requires significant resources, and any failure could adversely affect business operations[80]. - Changes in tax laws and regulations could increase tax complexity and adversely impact effective tax rates and cash flows[86]. Financial Position and Liquidity - The liquidity and long-term financing needs are significantly influenced by the operating cash flows of the company's agencies[65]. - The company may need to restructure debt or sell assets if operating cash flow significantly declines, impacting financial condition[65]. - The aggregate principal amount of long-term debt is $9.3 billion, with future interest payments totaling $2.1 billion[214]. - The company has a $3.5 billion unsecured multi-currency revolving credit facility, expiring on November 26, 2030, to support liquidity needs[208].

Revenue Growth and Financial Performance - Revenue increased from $115.8 million in 2023 to $396.3 million in 2024, and further to $852.5 million in 2025, indicating significant growth[69] - Net income recorded was $219.1 million in 2025, with net losses of $83.4 million and $26.3 million in 2024 and 2023 respectively[72] - In 2025, one end customer represented over 70% of total revenue, while the top three customers accounted for approximately 86%[82] - The company anticipates continued dependence on a limited number of end customers for a significant portion of revenue, which may increase in the future[82] Costs and Investments - The company expects to incur increasing costs to support anticipated future growth, including significant investments in research and development[72] - Research and development expenses for the years ended December 31, 2025, and 2024, were $304.0 million and $200.8 million, respectively, highlighting the company's commitment to innovation[106] Market and Customer Dynamics - The adoption and commercialization of AI technology remain uncertain, which could adversely affect the company's business and financial condition[65] - The company may face challenges in accurately predicting future revenue due to rapid market changes and dependence on a limited customer base[74] - The introduction of new products is critical for maintaining revenue growth, and failure to meet customer demands could lead to significant revenue declines[75] - The company may pursue acquisitions and investments, which could disrupt operations and affect financial results[65] - The company aims to maximize return on investment by aligning with customers to address high-value problem sets, particularly in cloud and AI markets[107] Manufacturing and Supply Chain Risks - The company relies on a limited number of third-party manufacturing partners, and any disruptions could adversely affect product marketing and sales[65] - The company faces risks related to third-party manufacturing partners, particularly with TSMC as the sole supplier for integrated circuits, which could impact product availability and revenue[97] - Geopolitical uncertainties in regions where manufacturing partners are located, such as Taiwan and China, could disrupt operations and affect financial performance[99] - The company does not maintain long-term supply contracts with manufacturing partners, which could lead to supply disruptions and negatively impact financial results[120] - The company relies on third-party manufacturing partners for production, and any issues with yields or quality could harm its reputation and customer relationships[131] Product Development and Market Acceptance - The company relies heavily on design wins, which are critical for generating sales and recouping investments in product development[87] - A design win does not guarantee sales, and delays or cancellations from customers can adversely affect financial results due to significant expenses incurred during the design process[88] - The qualification process for products can take several months, and even after qualification, there is no assurance of volume sales, which may lead to excess or obsolete inventory[105] - The complexity of products may lead to unforeseen delays or defects, adversely affecting market acceptance and operational costs[125] - The company may incur significant design and development costs for products that do not achieve market acceptance, adversely affecting financial results[203] Regulatory and Compliance Challenges - Compliance with emerging regulations, such as the EU AI Act, may increase research and development costs and operational burdens[95] - The company is subject to enhanced reporting and compliance obligations as a large accelerated filer, which may increase legal and financial compliance costs[244] - The company faces risks related to cybersecurity and data privacy, with evolving regulations that could increase compliance costs and expose it to significant penalties[160] - Changes in laws and regulations could materially affect the company's business, financial condition, and results of operations, particularly regarding export controls and international sales[182] Financial Risks and Market Conditions - Gross margins may decline due to factors such as customer and product mix, revenue mix, and competitive pricing dynamics, which could negatively impact financial results[108][109] - The company may offer favorable pricing to attract or retain customers, which could decrease product prices and adversely affect gross margins[110] - The company anticipates fluctuations in demand for its products, which could lead to excess inventory or missed revenue opportunities[119] - Economic conditions, including inflation and geopolitical developments, may adversely affect demand for the company's products and its overall financial performance[172] - The semiconductor industry is highly cyclical, with fluctuations in supply and demand impacting operating results and customer inventory levels[134] Intellectual Property and Legal Risks - The company has issued 26 patents in the United States and one in foreign jurisdictions, with 35 patent applications pending in the U.S. and five pending abroad as of December 31, 2025[204] - The company may face claims of intellectual property infringement, which could be costly and time-consuming to defend, potentially harming customer relationships[215] - The company’s ability to protect its intellectual property rights may be compromised in foreign jurisdictions, affecting competitive positioning[211] - The company may need to initiate litigation to protect its intellectual property, which could divert resources and negatively impact business operations[206] - The company’s agreements with customers often include indemnification clauses, which could lead to substantial expenses in the event of litigation[218] Stock and Investment Considerations - The company’s common stock has been publicly traded since March 2024, and its market price may continue to be volatile, impacting investment value[221] - The company expects to issue additional capital stock in the future, which may result in dilution to existing stockholders[231] - The company recognizes that fluctuations in revenue and operating results could cause its share price to decline[226] Operational and Management Challenges - Attracting and retaining qualified personnel, especially in design and technical roles, is critical for executing the business strategy[146] - Cybersecurity risks, including data breaches and system vulnerabilities, pose significant threats to the company's operations and reputation[150] - The company is transitioning to a new enterprise resource planning (ERP) system, which may lead to delays and unexpected costs, potentially impacting financial reporting and operational efficiency[167] - The company incurred stock-based compensation expense of $160.0 million during the year ended December 31, 2025[234] Cash and Financial Position - As of December 31, 2025, the company had cash and cash equivalents of $167.6 million and marketable securities totaling $1,021.2 million[340] - A hypothetical 100 basis point change in interest rates would change the fair value of the company's investments in marketable securities by $11.0 million as of December 31, 2025[341] - The company is exposed to market risks primarily due to fluctuations in interest rates and foreign currency exchange rates[339] - The reporting currency and functional currency of the company’s wholly owned foreign subsidiaries is the U.S. dollar[342] - All sales and the majority of operating expenses are transacted in U.S. dollars, minimizing foreign currency risk[342] - Foreign exchange gains and losses were not material for the years ended December 31, 2025, 2024, and 2023[342]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________ FORM 10-K ___________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to ____________ Commission File Number 001-32216 ADAMAS TRUST, INC. (Exact name of registrant as specified in its charter) (State ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________ FORM 10-K ___________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to ____________ Commission File Number 001-32216 ADAMAS TRUST, INC. (Exact name of registrant as specified in its charter) 90 Par ...